These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 542100)

  • 41. GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum.
    Starr MS
    Eur J Pharmacol; 1978 Apr; 48(3):325-8. PubMed ID: 639860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA.
    Hill JM
    Brain Res; 1985 Sep; 342(1):18-25. PubMed ID: 4041811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.
    Chassain C; Melon C; Salin P; Vitale F; Couraud S; Durif F; Kerkerian-Le Goff L; Gubellini P
    J Neurochem; 2016 Mar; 136(5):1004-16. PubMed ID: 26576509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of gamma-hydroxybutyrate and gamma-butyrolactone on dopamine synthesis and uptake by rat striatum.
    Bustos G; Kuhar MJ; Roth RH
    Biochem Pharmacol; 1972 Oct; 21(19):2649-52. PubMed ID: 4661622
    [No Abstract]   [Full Text] [Related]  

  • 45. Evidence for a glutamatergic projection from the zona incerta to the basal ganglia of rats.
    Heise CE; Mitrofanis J
    J Comp Neurol; 2004 Jan; 468(4):482-95. PubMed ID: 14689481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
    Orzi F; Fornai F; Blandini F
    Funct Neurol; 2000; 15(4):269-76. PubMed ID: 11213530
    [No Abstract]   [Full Text] [Related]  

  • 47. The relationships of aging changes in the basal ganglia to manifestations of Huntington's chorea.
    Finch CE
    Ann Neurol; 1980 May; 7(5):406-11. PubMed ID: 6446874
    [No Abstract]   [Full Text] [Related]  

  • 48. In vivo neurochemistry of primary focal hand dystonia: a magnetic resonance spectroscopic neurometabolite profiling study at 3T.
    Herath P; Gallea C; van der Veen JW; Horovitz SG; Hallett M
    Mov Disord; 2010 Dec; 25(16):2800-8. PubMed ID: 20979122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The absorption, distribution and excretion of 14 C-L-DOPA in the mouse and uptake into the cat corpus striatum].
    Yoshikawa M; Sato Y
    Yakugaku Zasshi; 1972 May; 92(5):551-64. PubMed ID: 5066310
    [No Abstract]   [Full Text] [Related]  

  • 50. A simple approach to study the effect of haloperidol on GABA functional activity in the nigro-striatal system.
    Cattabeni F; Maggi A; DeAngelis L; Bruno F; Racagni G
    J Neurochem; 1977 Jun; 28(6):1407-8. PubMed ID: 874507
    [No Abstract]   [Full Text] [Related]  

  • 51. [Relation between GABAergic and dopaminergic neurons in the basal ganglia].
    Kemel ML; Gauchy C; Girault JA; Besson JM; Glowinski J
    Encephale; 1987 Jul; 13 Spec No():169-71. PubMed ID: 3319524
    [No Abstract]   [Full Text] [Related]  

  • 52. Serotonergic regulation of the GABAergic transmission in the rat basal ganglia.
    Di Cara B; Samuel D; Salin P; Kerkerian-Le Goff L; Daszuta A
    Synapse; 2003 Nov; 50(2):144-50. PubMed ID: 12923817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra.
    Gale K
    Nature; 1980 Feb; 283(5747):569-70. PubMed ID: 7354838
    [No Abstract]   [Full Text] [Related]  

  • 54. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
    Ochi M; Shiozaki S; Kase H
    Neuroscience; 2004; 127(1):223-31. PubMed ID: 15219684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of GABA neurons in the expression of striatal motor functions.
    Di Chiara G; Porceddu ML; Imperato A; Morelli M
    Adv Biochem Psychopharmacol; 1981; 30():129-63. PubMed ID: 7036674
    [No Abstract]   [Full Text] [Related]  

  • 56. Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamineD1 receptor interaction in rat brain limbic regions but not basal ganglia.
    Mayfield RD; Jones BA; Miller HA; Simosky JK; Larson GA; Zahniser NR
    Synapse; 1999 Sep; 33(4):274-81. PubMed ID: 10421708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of content with synthesis, uptake and breakdown of GABA in substantia nigra of unoperated, hemitransected and kainate-treated rats.
    Starr M; Kilpatrick I
    Life Sci; 1981 Nov; 29(22):2281-7. PubMed ID: 7321760
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of tetanus toxin on transmitter release from substantia nigra and striatum in vitro.
    Collingridge GL; Collins GG; Davies J; James TA; Neal MJ; Tongroach P
    J Neurochem; 1980 Mar; 34(3):540-7. PubMed ID: 7354328
    [No Abstract]   [Full Text] [Related]  

  • 59. Regional differences in accumulation of tritium-labeled norepinephrine, 5-hydroxytryptamine and gamma-aminobutyric acid in brain slices of spider and rhesus monkey.
    Snyder SH; Hendley ED; Gfeller E
    Brain Res; 1969 Dec; 16(2):469-77. PubMed ID: 4982784
    [No Abstract]   [Full Text] [Related]  

  • 60. Disturbed GABAergic transmission in mutant Han-Wistar rats: further evidence for basal ganglia dysfunction.
    Schwarz M; Löscher W; Turski L; Sontag KH
    Brain Res; 1985 Nov; 347(2):258-67. PubMed ID: 2998553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.